Qatar launches FemTech accelerator with 240 startups from 47 countries

Qatar Science & Technology Park has kicked off its first international accelerator program focused on women's health technology. The QSTP x Merck FemTech Accelerator drew 240 applications from 47 countries, with 71% coming from female-led startups.

The program officially launched on April 20 with an opening session that brought together selected founders and applicants. It marks Qatar's push to become a regional hub for health innovation, particularly in areas where women have historically been underserved by medical technology.

How will it work?

The accelerator runs in two phases over several months. Phase I includes 40 founders participating in workshops and expert sessions covering digital health, impact measurement, and commercialization strategies.

During Phase II, a smaller group of selected startups will work with partner institutions in Qatar to test their solutions in real healthcare settings. Key partners include:

• Hamad Medical Corporation
• Sidra Medicine
• Weill Cornell Medicine-Qatar
• Qatar Research Development and Innovation (QRDI)

The program covers a wide range of women's health areas, from reproductive health and fertility to mental wellbeing, cancer screening, and maternal care. Startups will get access to pilot opportunities and potential partnerships with healthcare providers across the region.

Why does it matter?

Women's health has long been underfunded and underserved by traditional medical research and technology development. The World Health Organization estimates that women face significant gaps in healthcare access and treatment options across multiple conditions.

The strong response to this accelerator - particularly the high percentage of female founders - suggests there's substantial untapped innovation in this space. Many medical devices and treatments have historically been designed primarily for male physiology, leaving gaps that female entrepreneurs are now working to fill.

For Qatar specifically, this represents a strategic move to diversify its economy beyond oil and gas. The country has been investing heavily in becoming a knowledge economy hub, and healthcare innovation fits into that broader vision.

The context

The FemTech market has grown rapidly in recent years, though it still receives only a small fraction of overall healthcare investment. According to industry data, FemTech startups raised around $1 billion globally in 2023, but this represents less than 3% of total digital health funding.

Geographically, the QSTP program attracted applications from across regions:

• 33% from West Asia and North Africa
• 24.6% from Europe
• 15.8% from North America
• 10.4% from Africa

This is QSTP's first multi-country accelerator program, building on Qatar Foundation's existing efforts to support startups and scale-ups. The partnership with Merck, the German pharmaceutical and technology company, provides access to industry expertise and potential commercialization pathways.

"The level of interest and the quality of applications reflect both the urgency and the opportunity within women's health," said Rama Chakaki, President of QSTP. "It is encouraging to see a strong representation of female founders developing solutions across critical areas."